The global clinical trial supply services market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of clinical trials and growing demand for outsourcing clinical trial supply services.
Manufacturing segment accounted for the largest share in the global clinical trial supply services market in 2018, followed by packaging and labeling segment. The manufacturing segment is expected to maintain its dominance throughout the forecast period due to high demand for outsourcing manufacturing activities from pharmaceutical companies and biotechnology firms. Packaging and labeling segment is projected to grow at a higher CAGR during the forecast period due to increasing demand for outsourcing packaging activities from pharmaceutical companies and biotechnology firms as well as rising need for quality control in drug production processes.
Oncology application accounted for the largest share in global clinical trial supply services market in 2018, followed by cardiovascular diseases application. Oncology application is projected to maintain its dominance throughout the forecast period due to high incidence rates of cancer globally which will lead towards increased number of oncology trials globally over time; whereas cardiovascular diseases are projected be among fastest-growing applications with an estimated CAGR of 6%. Respiratory diseases are also expected be among fastest-growing applications with an estimated CAGR of 7%.
Some Of The Growth Factors Of This Market:
- Increasing government regulations on drug development and approval are also expected to fuel the growth of this market over the forecast period (2017-2022).
- The increasing number of mergers and acquisitions in this industry is also expected to drive growth in this market over the forecast period (2017-2022) 4) Increasing investments by pharmaceutical companies in research & development activities will provide opportunities for suppliers in this industry over the forecast period (2017-2022).
Industry Growth Insights published a new data on “Clinical Trial Supply Services Market”. The research report is titled “Clinical Trial Supply Services Market research by Types (Manufacturing, Packaging and Labeling, Logistics and Distribution, Clinical Trial Supply Service), By Applications (Oncology, Cardiovascular Diseases, Respiratory Diseases, CNS And Mental Disorders, Dermatology, Blood Disorders, Infectious Diseases, Others), By Players/Companies Parexel International, ALMAC Group, Catalent Pharma Solutions, Piramal Pharma Solutions, Shertech Manufacturing, Thermo Fisher Scientific, PCI Services, Patheon, Inc., Sharp Packaging Services, Biocair, Movianto, Klifo A/S., Clinical Trial Supply Service”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Clinical Trial Supply Services Market Research Report
By Type
Manufacturing, Packaging and Labeling, Logistics and Distribution, Clinical Trial Supply Service
By Application
Oncology, Cardiovascular Diseases, Respiratory Diseases, CNS And Mental Disorders, Dermatology, Blood Disorders, Infectious Diseases, Others
By Companies
Parexel International, ALMAC Group, Catalent Pharma Solutions, Piramal Pharma Solutions, Shertech Manufacturing, Thermo Fisher Scientific, PCI Services, Patheon, Inc., Sharp Packaging Services, Biocair, Movianto, Klifo A/S., Clinical Trial Supply Service
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Clinical Trial Supply Services Market Report Segments:
The global Clinical Trial Supply Services market is segmented on the basis of:
Types
Manufacturing, Packaging and Labeling, Logistics and Distribution, Clinical Trial Supply Service
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Cardiovascular Diseases, Respiratory Diseases, CNS And Mental Disorders, Dermatology, Blood Disorders, Infectious Diseases, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Parexel International
- ALMAC Group
- Catalent Pharma Solutions
- Piramal Pharma Solutions
- Shertech Manufacturing
- Thermo Fisher Scientific
- PCI Services
- Patheon, Inc.
- Sharp Packaging Services
- Biocair
- Movianto
- Klifo A/S.
- Clinical Trial Supply Service
Highlights of The Clinical Trial Supply Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Manufacturing
- Packaging and Labeling
- Logistics and Distribution
- Clinical Trial Supply Service
- By Application:
- Oncology
- Cardiovascular Diseases
- Respiratory Diseases
- CNS And Mental Disorders
- Dermatology
- Blood Disorders
- Infectious Diseases
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Clinical Trial Supply Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Clinical Trial Supply Services (CTSS) is a global clinical trial management company. It provides services to sponsors, investigators, and participants in the conduct of clinical trials. CTSS helps sponsors manage their trials by providing them with resources such as study sites, recruitment centers, and contract research organizations (CROs). Investigators can use CTSS' services to manage their studies by providing them with tools such as patient registries and tracking systems. Participants can use CTSS' services to find study sites and enroll in trials.
Some of the major companies in the clinical trial supply services market are Parexel International, ALMAC Group, Catalent Pharma Solutions, Piramal Pharma Solutions, Shertech Manufacturing, Thermo Fisher Scientific, PCI Services, Patheon, Inc., Sharp Packaging Services, Biocair, Movianto, Klifo A/S., Clinical Trial Supply Service.
The clinical trial supply services market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Clinical Trial Supply Services Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Clinical Trial Supply Services Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Clinical Trial Supply Services Market - Supply Chain
4.5. Global Clinical Trial Supply Services Market Forecast
4.5.1. Clinical Trial Supply Services Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Clinical Trial Supply Services Market Size (000 Units) and Y-o-Y Growth
4.5.3. Clinical Trial Supply Services Market Absolute $ Opportunity
5. Global Clinical Trial Supply Services Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Clinical Trial Supply Services Market Size and Volume Forecast by Type
5.3.1. Manufacturing
5.3.2. Packaging and Labeling
5.3.3. Logistics and Distribution
5.3.4. Clinical Trial Supply Service
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Clinical Trial Supply Services Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Clinical Trial Supply Services Market Size and Volume Forecast by Application
6.3.1. Oncology
6.3.2. Cardiovascular Diseases
6.3.3. Respiratory Diseases
6.3.4. CNS And Mental Disorders
6.3.5. Dermatology
6.3.6. Blood Disorders
6.3.7. Infectious Diseases
6.3.8. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Clinical Trial Supply Services Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Clinical Trial Supply Services Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Clinical Trial Supply Services Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Clinical Trial Supply Services Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Clinical Trial Supply Services Demand Share Forecast, 2019-2026
9. North America Clinical Trial Supply Services Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Clinical Trial Supply Services Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Clinical Trial Supply Services Market Size and Volume Forecast by Application
9.4.1. Oncology
9.4.2. Cardiovascular Diseases
9.4.3. Respiratory Diseases
9.4.4. CNS And Mental Disorders
9.4.5. Dermatology
9.4.6. Blood Disorders
9.4.7. Infectious Diseases
9.4.8. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Clinical Trial Supply Services Market Size and Volume Forecast by Type
9.7.1. Manufacturing
9.7.2. Packaging and Labeling
9.7.3. Logistics and Distribution
9.7.4. Clinical Trial Supply Service
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Clinical Trial Supply Services Demand Share Forecast, 2019-2026
10. Latin America Clinical Trial Supply Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Clinical Trial Supply Services Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Clinical Trial Supply Services Market Size and Volume Forecast by Application
10.4.1. Oncology
10.4.2. Cardiovascular Diseases
10.4.3. Respiratory Diseases
10.4.4. CNS And Mental Disorders
10.4.5. Dermatology
10.4.6. Blood Disorders
10.4.7. Infectious Diseases
10.4.8. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Clinical Trial Supply Services Market Size and Volume Forecast by Type
10.7.1. Manufacturing
10.7.2. Packaging and Labeling
10.7.3. Logistics and Distribution
10.7.4. Clinical Trial Supply Service
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Clinical Trial Supply Services Demand Share Forecast, 2019-2026
11. Europe Clinical Trial Supply Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Clinical Trial Supply Services Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Clinical Trial Supply Services Market Size and Volume Forecast by Application
11.4.1. Oncology
11.4.2. Cardiovascular Diseases
11.4.3. Respiratory Diseases
11.4.4. CNS And Mental Disorders
11.4.5. Dermatology
11.4.6. Blood Disorders
11.4.7. Infectious Diseases
11.4.8. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Clinical Trial Supply Services Market Size and Volume Forecast by Type
11.7.1. Manufacturing
11.7.2. Packaging and Labeling
11.7.3. Logistics and Distribution
11.7.4. Clinical Trial Supply Service
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Clinical Trial Supply Services Demand Share, 2019-2026
12. Asia Pacific Clinical Trial Supply Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Clinical Trial Supply Services Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Clinical Trial Supply Services Market Size and Volume Forecast by Application
12.4.1. Oncology
12.4.2. Cardiovascular Diseases
12.4.3. Respiratory Diseases
12.4.4. CNS And Mental Disorders
12.4.5. Dermatology
12.4.6. Blood Disorders
12.4.7. Infectious Diseases
12.4.8. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Clinical Trial Supply Services Market Size and Volume Forecast by Type
12.7.1. Manufacturing
12.7.2. Packaging and Labeling
12.7.3. Logistics and Distribution
12.7.4. Clinical Trial Supply Service
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Clinical Trial Supply Services Demand Share, 2019-2026
13. Middle East & Africa Clinical Trial Supply Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Clinical Trial Supply Services Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Clinical Trial Supply Services Market Size and Volume Forecast by Application
13.4.1. Oncology
13.4.2. Cardiovascular Diseases
13.4.3. Respiratory Diseases
13.4.4. CNS And Mental Disorders
13.4.5. Dermatology
13.4.6. Blood Disorders
13.4.7. Infectious Diseases
13.4.8. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Clinical Trial Supply Services Market Size and Volume Forecast by Type
13.7.1. Manufacturing
13.7.2. Packaging and Labeling
13.7.3. Logistics and Distribution
13.7.4. Clinical Trial Supply Service
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Clinical Trial Supply Services Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Clinical Trial Supply Services Market: Market Share Analysis
14.2. Clinical Trial Supply Services Distributors and Customers
14.3. Clinical Trial Supply Services Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Parexel International
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. ALMAC Group
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Catalent Pharma Solutions
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Piramal Pharma Solutions
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Shertech Manufacturing
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Thermo Fisher Scientific
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. PCI Services
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Patheon, Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Sharp Packaging Services
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Biocair
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Movianto
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Klifo A/S.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Clinical Trial Supply Service
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
&
